Posted On: 08/03/2014 11:27:29 AM
Post# of 63828
$TBIO at resistance $3.98
O/S shares 7,353,695 .
10-Q 5/15/14
Website
Analysts Consensus
Recent trades & PRs
Nasdaq
Transgenomic Announces Issuance of New European Patent
Covering COLD-PCR Technologies
7/31/2014 7:00:00 AM - Business Wire
Transgenomic to Hold Second Quarter Financial Results Conference Call
on August 6, 2014
7/30/2014 4:30:00 PM - Business Wire
Transgenomic Sells Rights to SURVEYOR Mutation Detection Technology
and Assets to Integrated DNA Technologies, Inc.
7/2/2014 7:00:00 AM - Business Wire
Collaborative Studies Validating Transgenomic’s ICE COLD-PCR Technology
Highlighted in Educational Materials at Major Upcoming Cancer Meeting
5/29/2014 10:00:00 AM - Business Wire
Transgenomic Licenses Exclusive Rights
to Multiplexed ICE COLD-PCRTM Technology
5/28/2014 7:00:00 AM - Business Wire
O/S shares 7,353,695 .
10-Q 5/15/14
Website
Analysts Consensus
Recent trades & PRs
Nasdaq
Transgenomic Announces Issuance of New European Patent
Covering COLD-PCR Technologies
7/31/2014 7:00:00 AM - Business Wire
Transgenomic to Hold Second Quarter Financial Results Conference Call
on August 6, 2014
7/30/2014 4:30:00 PM - Business Wire
Transgenomic Sells Rights to SURVEYOR Mutation Detection Technology
and Assets to Integrated DNA Technologies, Inc.
7/2/2014 7:00:00 AM - Business Wire
Collaborative Studies Validating Transgenomic’s ICE COLD-PCR Technology
Highlighted in Educational Materials at Major Upcoming Cancer Meeting
5/29/2014 10:00:00 AM - Business Wire
Transgenomic Licenses Exclusive Rights
to Multiplexed ICE COLD-PCRTM Technology
5/28/2014 7:00:00 AM - Business Wire
(0)
(0)
